CN Stock MarketDetailed Quotes
300238 Guanhao Biotech
- 14.37
- +0.29+2.06%
Market Closed Dec 12 15:00 CST
3.81BMarket Cap217.73P/E (TTM)
14.37High13.90Low102.85KlotVolume14.05Open14.08Pre Close145.91MTurnover3.88%Turnover Ratio122.82P/E (Static)265.16MShares16.1352wk High6.97P/B3.81BFloat Cap7.4852wk Low16.90Limit Up265.13MShs Float62.97Historical High11.26Limit Down3.34%Amplitude6.24Historical Low--Dividend TTM14.19Avg Price48.90KlotAsk--Div YieldTTM100Lot Size52.72KlotBid
Guanhao Biotech Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | -9.97%278.14M | -10.02%189.7M | -18.85%91.44M | 7.13%404.18M | 5.09%308.95M | 3.91%210.81M | -8.33%112.68M | -22.84%377.29M | -20.97%293.98M | -22.68%202.88M |
| Operating revenue | -9.97%278.14M | -10.02%189.7M | -18.85%91.44M | 7.13%404.18M | 5.09%308.95M | 3.91%210.81M | -8.33%112.68M | -22.84%377.29M | -20.97%293.98M | -22.68%202.88M |
| Other operating revenue | ---- | 12.42%6.76M | ---- | -5.48%15.38M | ---- | -33.81%6.02M | ---- | -38.34%16.27M | ---- | -23.94%9.09M |
| Total operating cost | -3.14%249.92M | -9.69%160.97M | -17.56%71.75M | 0.08%360.49M | -1.93%258.01M | 2.30%178.23M | -9.00%87.03M | -14.62%360.22M | -18.37%263.09M | -21.82%174.22M |
| Operating cost | -1.78%59.42M | -10.91%42.08M | -21.61%20.07M | -5.86%84.37M | -11.38%60.49M | -2.93%47.23M | -15.73%25.61M | -26.35%89.62M | -23.78%68.26M | -21.17%48.66M |
| Operating tax surcharges | -8.63%2.86M | -9.36%1.95M | -14.70%853.81K | 2.87%4.37M | 44.42%3.13M | 23.11%2.15M | 20.21%1M | -10.30%4.25M | -36.68%2.16M | -21.19%1.75M |
| Operating expense | -4.84%118.26M | -10.97%73.73M | -16.43%30.73M | 6.48%166.54M | 8.49%124.26M | 13.98%82.82M | -11.69%36.78M | -15.56%156.4M | -22.39%114.53M | -31.38%72.66M |
| Administration expense | 9.26%40.65M | 12.88%26.77M | -8.25%12.47M | 2.70%55.37M | 4.03%37.2M | -1.00%23.71M | 15.74%13.6M | -5.16%53.91M | -14.59%35.76M | -20.85%23.95M |
| Financial expense | -72.78%647.42K | -80.61%408.84K | -72.54%133.94K | -3.14%5.35M | -41.85%2.38M | -27.62%2.11M | -61.50%487.81K | -18.91%5.52M | -31.68%4.09M | -17.86%2.91M |
| -Interest expense (Financial expense) | -66.94%459.93K | -69.28%313.08K | -69.66%159.79K | -56.66%1.78M | -60.70%1.39M | -70.52%1.02M | -61.53%526.67K | -44.16%4.11M | -39.75%3.54M | -16.27%3.46M |
| -Interest Income (Financial expense) | 59.07%-470.02K | 63.84%-275.5K | 64.46%-130.99K | 32.19%-1.5M | 32.90%-1.15M | 35.91%-761.85K | 29.10%-368.61K | -0.97%-2.22M | -17.91%-1.71M | -22.61%-1.19M |
| Research and development | -8.03%28.09M | -20.69%16.03M | -21.78%7.48M | -11.90%44.5M | -20.20%30.55M | -16.82%20.21M | -2.08%9.57M | 8.36%50.52M | 12.95%38.28M | 26.49%24.3M |
| Credit Impairment Loss | -38.18%-6.46M | -49.28%-4.44M | 21.81%-524.39K | -42.46%-9.28M | -861.93%-4.68M | -563.57%-2.97M | 29.02%-670.64K | -3.73%-6.51M | 80.69%-486.04K | 140.18%641.24K |
| Asset Impairment Loss | 101.08%35.41K | -95.19%113.56K | 345.27%264.39K | 98.78%-3.89M | 98.82%-3.27M | 100.85%2.36M | 12.98%-107.79K | -8,179.83%-318.26M | -16,731.99%-277.4M | -21,490.31%-276.81M |
| Other net revenue | 149.88%3.28M | -311.30%-2.67M | -60.55%830.39K | 96.86%-9.7M | 97.49%-6.58M | 100.48%1.27M | 585.27%2.1M | -2,235.06%-309.11M | -1,644.89%-262.38M | -3,888.27%-266.21M |
| Invest income | 122.73%805.73K | 80.82%-404.01K | -38.54%-129.02K | 66.91%-3.64M | -71.52%-3.55M | -33.56%-2.11M | 87.74%-93.12K | -134.83%-11M | 24.41%-2.07M | 38.64%-1.58M |
| -Including: Investment income associates | -30.96%-504.81K | -46.73%-377.17K | -38.54%-129.02K | 95.75%-480.53K | 83.66%-385.47K | 83.70%-257.05K | 87.74%-93.12K | -141.23%-11.29M | 13.72%-2.36M | 38.64%-1.58M |
| Asset deal income | 129.29%1.47K | 117.63%885 | 121.72%1.09K | 3,142.03%924.11K | -117.61%-5.02K | -117.69%-5.02K | -117.66%-5.02K | -91.43%28.5K | -87.36%28.5K | -90.95%28.38K |
| Other revenue | 81.07%8.9M | -48.56%2.05M | -59.14%1.22M | -76.79%6.18M | -71.98%4.92M | -65.32%3.99M | 41.52%2.98M | -7.99%26.64M | -25.85%17.54M | -5.41%11.5M |
| Operating profit | -28.99%31.5M | -23.02%26.06M | -26.07%20.52M | 111.64%33.99M | 119.16%44.35M | 114.25%33.85M | 0.61%27.75M | -458.09%-292.04M | -447.22%-231.48M | -609.88%-237.56M |
| Add:Non operating Income | -88.52%11.59K | -97.63%2.29K | -99.75%270.15 | -97.11%11.17K | -75.43%100.96K | -65.91%96.52K | -17.18%109.35K | -33.39%386.51K | -28.73%410.94K | 163.84%283.09K |
| Less:Non operating expense | -62.99%174.83K | 240.38%180.19K | 1.61%40.33K | 105.84%1.91M | 25.95%472.34K | -82.14%52.94K | -47.59%39.69K | 1,039.76%928.15K | 869.03%375.02K | 3,062.55%296.46K |
| Total profit | -28.76%31.33M | -23.65%25.88M | -26.39%20.48M | 110.97%32.09M | 119.00%43.98M | 114.27%33.89M | 0.65%27.82M | -456.57%-292.58M | -444.39%-231.45M | -608.84%-237.57M |
| Less:Income tax cost | 82.48%10.68M | 147.28%9.12M | 33.45%5.01M | -68.57%11.02M | -13.98%5.85M | -61.54%3.69M | -40.28%3.75M | 11.93%35.06M | -64.42%6.8M | -30.03%9.59M |
| Net profit | -45.82%20.66M | -44.52%16.76M | -35.72%15.47M | 106.43%21.07M | 116.01%38.13M | 112.22%30.21M | 12.69%24.07M | -745.78%-327.64M | -595.43%-238.25M | -849.32%-247.16M |
| Net profit from continuing operation | -45.82%20.66M | -44.52%16.76M | -35.72%15.47M | 106.45%21.07M | 116.01%38.13M | 112.22%30.21M | 12.69%24.07M | -727.23%-326.64M | -595.43%-238.25M | -849.32%-247.16M |
| Net income from discontinuing operating | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 25.29%-1M | ---- | ---- |
| Less:Minority Profit | -128.70%-7.18M | -530.53%-3.39M | -44.69%1.08M | 49.87%-9.93M | 52.91%-3.14M | 83.06%-537.5K | 570.42%1.96M | 13.67%-19.81M | 42.99%-6.66M | 56.18%-3.17M |
| Net profit of parent company owners | -32.55%27.84M | -34.46%20.15M | -34.92%14.39M | 110.07%31.01M | 117.82%41.27M | 112.60%30.74M | 1.54%22.12M | -517.75%-307.82M | -487.40%-231.58M | -706.56%-243.99M |
| Earning per share | ||||||||||
| Basic earning per share | -37.50%0.1 | -33.33%0.08 | -37.50%0.05 | 110.34%0.12 | 118.39%0.16 | 113.04%0.12 | 0.00%0.08 | -514.29%-1.16 | -478.26%-0.87 | -713.33%-0.92 |
| Diluted earning per share | -37.50%0.1 | -33.33%0.08 | -37.50%0.05 | 110.34%0.12 | 118.39%0.16 | 113.04%0.12 | 0.00%0.08 | -514.29%-1.16 | -478.26%-0.87 | -713.33%-0.92 |
| Other composite income | -104.20%-112.1K | -103.40%-41.35K | -104.68%-80.93K | -36.38%4.24M | 27.20%2.67M | -68.70%1.22M | 433.16%1.73M | 134.24%6.67M | 263.09%2.1M | 461.34%3.88M |
| Other composite income of parent company owners | -104.20%-112.1K | -103.40%-41.35K | -104.68%-80.93K | -36.38%4.24M | 27.20%2.67M | -68.70%1.22M | 433.16%1.73M | 134.24%6.67M | 263.09%2.1M | 461.34%3.88M |
| Total composite income | -49.64%20.55M | -46.79%16.72M | -40.34%15.39M | 107.89%25.32M | 117.28%40.8M | 112.92%31.42M | 23.80%25.8M | -1,126.96%-320.97M | -604.57%-236.15M | -862.39%-243.27M |
| Total composite income of parent company owners | -36.91%27.72M | -37.09%20.11M | -39.99%14.31M | 111.70%35.25M | 119.15%43.94M | 113.31%31.96M | 12.16%23.85M | -655.58%-301.15M | -492.34%-229.49M | -713.29%-240.1M |
| Total composite income of minority owners | -128.70%-7.18M | -530.53%-3.39M | -44.69%1.08M | 49.87%-9.93M | 52.91%-3.14M | 83.06%-537.5K | 570.42%1.96M | 13.67%-19.81M | 42.99%-6.66M | 56.18%-3.17M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Daxin Certified Public Accountants (Special General Partnership) | -- | -- | -- | Daxin Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
CN
Overall
Symbol
Price
% Chg
No Data
